Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum Proteomic Study of Women With Obsessive-Compulsive Disorder, Washing Subtype.
Zamanian-Azodi M, Rezaei-Tavirani M, Mahboubi M, Hamidpour M, Rezaei Tavirani M, Hamdieh M, Rostami-Nejad M, Nejadi N, Derakhshan MK. Zamanian-Azodi M, et al. Among authors: derakhshan mk. Basic Clin Neurosci. 2018 Sep-Oct;9(5):337-346. doi: 10.32598/bcn.9.5.337. Epub 2018 Sep 1. Basic Clin Neurosci. 2018. PMID: 30719248 Free PMC article.
Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach.
Zamanian Azodi M, Rezaei Tavirani M, Arefi Oskouie A, Hamdieh M, Derakhshan MK, Ahmadzadeh A, Zayeri F, Nejadi N, Rezaei Tavirani M, Mansouri V, Rostami-Nejad M, Vafaee R. Zamanian Azodi M, et al. Among authors: derakhshan mk. Iran J Pharm Res. 2017 Summer;16(3):1264-1271. Iran J Pharm Res. 2017. PMID: 29201116 Free PMC article.
Psychometric properties of the Persian version of the somatic symptom disorder-B Criteria Scale (SSD-12) in community and clinical samples.
Abasi I, Ghapanchi A, Toussaint A, Bitarafan M, Zarabi H, Derakhshan FS, Banihashem S, Mohammadi N, Ghasemzadeh MR, Derakhshan MK. Abasi I, et al. Among authors: derakhshan mk. Gen Hosp Psychiatry. 2022 Sep-Oct;78:1-8. doi: 10.1016/j.genhosppsych.2022.04.010. Epub 2022 Apr 27. Gen Hosp Psychiatry. 2022. PMID: 35728363
A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S. Salimi S, et al. Among authors: derakhshan mk. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):726-32. doi: 10.1016/j.pnpbp.2007.11.021. Epub 2007 Nov 23. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18096287 Clinical Trial.
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S. Amiri A, et al. Among authors: derakhshan mk. Hum Psychopharmacol. 2008 Mar;23(2):79-86. doi: 10.1002/hup.902. Hum Psychopharmacol. 2008. PMID: 17972359 Clinical Trial.